ArticleFrontiers in pediatrics2026
A 10-year trend in the incidence of retinopathy of prematurity in Sichuan, China.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimizing retinopathy of prematurity screening in China using a single objective criterion: a 10-year retrospective analysis.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the 10-year incidence trend of retinopathy of prematurity (ROP) in Sichuan, China, and explore associated clinical factors and screening strategies. Methods: In this single-center retrospective study, 603 premature infants undergoing ROP screening between 2014 and 2023 were included. Incidence rates were calculated across five biennial periods, stratified by birth weight and gestational age. Cochran-Armitage test assessed trends; a decision model evaluated screening thresholds; correlation/regression analyses identified clinical associations. Results: Overall ROP incidence was 19.2% (116/603); Type 1 ROP incidence was 5.1% (31/603). ROP incidence declined from 22.8% to 16.5%, and Type 1 ROP from 5.9% to 4.2% over the study period. No Type 1 ROP occurred in infants >1,500 g or >32 weeks after 2018, with a statistically significant downward trend ( Conclusion: ROP incidence in Sichuan declined significantly over the past decade. Sepsis is a key risk factor, while improved oxygen therapy and breastfeeding are protective. Adjusting the screening threshold to <1,500 g may enhance screening cost-effectiveness for tertiary medical centers in Sichuan while maintaining a high detection rate for severe ROP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.